Engleman Edgar
- SEC CIK
- 0001227162
No open-market purchases or sales filed in the past year.
Current role at each company
- BOLT Bolt Biotherapeutics, Inc.Directoras of Dec 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Engleman Edgar as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 (view filing) | Nov 29-30 | 2 days | Engleman EdgarDirector | SSale | −148.9K | $0.8687 | −$129.3K | −37.2%251.5K after | 4 lots |
| Nov 22, 2023 (view filing) | Nov 21 | 1 day | Engleman EdgarDirector | SSale | −1.94K | $0.90 | −$1.75K | −0.7%269.6K after | 2 lots |
| Nov 20, 2023 (view filing) | Nov 16-20 | 4 days | Engleman EdgarDirector | SSale | −49.2K | $0.9289 | −$45.7K | −15.4%269.8K after | 6 lots |